Vivos Therapeutics, Inc. (VVOS) Debt by Year
Vivos Therapeutics, Inc. carried $469K in long-term debt against $2.0M in cash and equivalents at the end of fiscal year 2025. Long-term debt fell 60.9% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Vivos Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VVOS Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
VVOS Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $366K-95.3% | $418K | $469K-60.9% | $8.4M+598.3% | $7.8M+546.7% | N/A | $1.2M0.0% | $1.2M0.0% | $1.2M0.0% | N/A | $1.2M | $1.2M |
| Cash & Equivalents | $1.8M-59.7% | $2.1M-9.9% | $2.0M-67.6% | $3.1M-51.1% | $4.4M-36.2% | $2.3M-10.3% | $6.3M+281.0% | $6.3M+538.8% | $6.9M+75.1% | $2.6M-62.9% | $1.6M-53.3% | $988K-85.3% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Vivos Therapeutics, Inc. financials
Frequently Asked Questions
What was Vivos Therapeutics, Inc.'s long-term debt in fiscal year 2025?
Vivos Therapeutics, Inc. carried $469K in long-term debt against $2.0M in cash and equivalents at the end of fiscal year 2025.
How fast is Vivos Therapeutics, Inc.'s long-term debt growing?
Vivos Therapeutics, Inc. (VVOS) long-term debt fell by 60.9% year over year, from $1.2M to $469K in fiscal year 2025.
How has Vivos Therapeutics, Inc.'s long-term debt changed over the years?
Across the 7 fiscal years this page covers, Vivos Therapeutics, Inc. (VVOS) long-term debt went from $3.7M in fiscal year 2019 to $469K in fiscal year 2025.
What was Vivos Therapeutics, Inc.'s long-term debt in the most recent quarter?
Vivos Therapeutics, Inc. (VVOS) reported $366K in long-term debt in Q2 2026. This represents a decrease of 95.3% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Vivos Therapeutics, Inc. (VVOS) reported on that line in every period on record.